Profile data is unavailable for this security.
About the company
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics technology company. The Company is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, that leads to esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). The Company’s products include EsoGuard and EsoCheck. EsoGuard is a bisulfite-converted next generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in office procedures. It consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. It is also developing EsoCure, is an Esophageal Ablation Device, which is a technology that allows a clinician to treat dysplastic BE.
- Revenue in USD (TTM)4.40m
- Net income in USD-65.84m
- Incorporated2018
- Employees72.00
- LocationLucid Diagnostics Inc360 Madison Avenue, 25Th FloorNEW YORK 10017United StatesUSA
- Phone+1 (212) 949-4319
- Fax+1 (302) 655-5049
- Websitehttps://www.luciddx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LENSAR Inc | 59.14m | -51.52m | 146.08m | 140.00 | -- | -- | -- | 2.47 | -4.39 | -4.39 | 4.99 | -1.02 | 0.8946 | 1.79 | 11.51 | 422,435.70 | -77.94 | -32.69 | -121.49 | -38.95 | 46.15 | 51.51 | -87.12 | -54.77 | 0.6671 | -- | -- | -- | 26.87 | 11.87 | -118.34 | -- | -40.48 | -- |
| Anika Therapeutics Inc | 82.20m | 13.91m | 147.24m | 288.00 | 10.84 | 1.00 | 7.28 | 1.79 | 0.9419 | -2.28 | 5.70 | 10.18 | 0.3907 | 0.486 | 3.25 | 285,430.60 | 6.61 | -1.87 | 7.39 | -2.06 | 54.29 | 60.74 | 16.92 | -4.73 | 4.47 | -- | 0.00 | -- | -0.7327 | 0.9077 | -156.70 | -- | 24.14 | -- |
| Apyx Medical Inc | 47.90m | -14.54m | 152.57m | 220.00 | -- | 24.06 | -- | 3.19 | -0.3644 | -0.3644 | 1.19 | 0.1546 | 0.8113 | 1.97 | 3.68 | 217,736.40 | -24.60 | -27.67 | -29.90 | -33.35 | 62.65 | 64.81 | -30.32 | -43.61 | 3.61 | -2.04 | 0.8507 | -- | -8.11 | 11.24 | -25.38 | -- | -11.11 | -- |
| InfuSystem Holdings Inc | 141.05m | 5.52m | 153.33m | 502.00 | 28.82 | 2.76 | 8.09 | 1.09 | 0.2616 | 0.2616 | 6.65 | 2.73 | 1.38 | 10.25 | 5.79 | 280,984.10 | 5.41 | 4.50 | 6.56 | 5.46 | 55.35 | 55.24 | 3.92 | 3.86 | 1.60 | 7.73 | 0.274 | 0.00 | 7.22 | 10.70 | 168.92 | 11.50 | -4.62 | -- |
| Cibus Inc | 3.79m | -118.90m | 156.17m | 157.00 | -- | 2.40 | -- | 41.16 | -3.26 | -3.26 | 0.0972 | 0.9588 | 0.0109 | -- | 4.23 | 24,165.61 | -36.11 | -80.24 | -39.32 | -89.98 | -- | -- | -3,322.54 | -1,268.46 | -- | -2.18 | 0.8131 | -- | 134.56 | -10.19 | 6.07 | -- | -22.92 | -- |
| Inogen Inc | 347.03m | -25.38m | 156.38m | 766.00 | -- | 0.7931 | -- | 0.4506 | -1.00 | -1.00 | 13.47 | 7.26 | 1.13 | 7.92 | 9.30 | 453,039.20 | -8.28 | -11.40 | -10.67 | -13.50 | 44.76 | 44.22 | -7.31 | -13.82 | 2.75 | -- | 0.00 | -- | 6.35 | -1.49 | 64.97 | -- | 38.15 | -- |
| Nano-X Imaging Ltd | 12.30m | -55.71m | 157.80m | 165.00 | -- | 0.9513 | -- | 12.83 | -0.8839 | -0.8839 | 0.195 | 2.40 | 0.0683 | 13.17 | 7.18 | 74,557.58 | -30.95 | -28.17 | -33.30 | -31.20 | -98.04 | -- | -452.82 | -1,072.25 | 3.93 | -- | 0.0201 | -- | 13.91 | -- | 11.95 | -- | 85.79 | -- |
| Acme United Corp | 194.96m | 10.02m | 168.37m | 633.00 | 18.17 | 1.45 | 10.36 | 0.8636 | 2.43 | 2.43 | 47.35 | 30.41 | 1.15 | 2.03 | 6.35 | 307,993.70 | 5.92 | 7.26 | 6.81 | 8.54 | 39.51 | 36.34 | 5.14 | 5.68 | 1.75 | 8.57 | 0.1962 | 18.40 | 1.56 | 6.42 | -43.67 | 12.70 | 33.59 | 4.56 |
| Citrine Global Corp | 0.00 | -1.74m | 169.70m | 18.00 | -- | -- | -- | -- | -0.0016 | -0.0016 | 0.00 | -0.0031 | 0.00 | -- | -- | 0.00 | -118.80 | -238.43 | -- | -- | -- | -- | -- | -186,483.40 | -- | -2.10 | -- | -- | -- | -- | 25.99 | -- | -- | -- |
| Accendra Health Inc | 6.71bn | -410.53m | 173.26m | 13.50k | -- | -- | -- | 0.0258 | -5.33 | -17.41 | 86.97 | -5.56 | 1.47 | 7.59 | 15.52 | 496,837.20 | -9.01 | -0.3346 | -17.40 | -0.5248 | 26.13 | 18.20 | -6.12 | -0.146 | 0.8386 | 1.67 | 1.25 | -- | 3.55 | 3.04 | -778.15 | -- | 34.30 | -- |
| Rapid Micro Biosystems Inc | 30.52m | -44.29m | 173.30m | 163.00 | -- | 3.91 | -- | 5.68 | -0.9984 | -0.9984 | 0.6884 | 1.00 | 0.3209 | 1.33 | 6.40 | 187,257.70 | -46.56 | -38.13 | -56.14 | -43.36 | 7.72 | -27.98 | -145.11 | -253.02 | 2.95 | -- | 0.3003 | -- | 24.57 | 11.18 | 10.63 | -- | -4.24 | -- |
| Lucid Diagnostics Inc | 4.40m | -65.84m | 174.13m | 72.00 | -- | -- | -- | 39.58 | -0.8968 | -0.8968 | 0.0526 | 0.1973 | 0.1161 | 12.24 | 14.94 | 61,097.22 | -140.60 | -139.37 | -301.55 | -297.39 | -58.13 | -- | -1,211.30 | -2,492.79 | 1.88 | -- | 0.4633 | -- | 79.00 | -- | -0.6817 | -- | -- | -- |
| Edap Tms SA (ADR) | 75.71m | -23.29m | 174.59m | 310.00 | -- | 6.31 | -- | 2.31 | -0.6221 | -0.6221 | 2.02 | 0.7401 | 0.9081 | 2.08 | 3.62 | 244,219.90 | -27.94 | -11.18 | -49.24 | -15.86 | 43.24 | 42.19 | -30.77 | -16.63 | 0.9729 | -- | 0.2062 | -- | 6.11 | 7.38 | 10.20 | -- | 55.92 | -- |
| Stereotaxis Inc | 30.07m | -24.91m | 185.72m | 139.00 | -- | 28.93 | -- | 6.18 | -0.281 | -0.281 | 0.3393 | 0.1266 | 0.6232 | 1.47 | 4.54 | 216,359.70 | -48.96 | -31.30 | -85.25 | -43.31 | 53.07 | 62.81 | -78.56 | -56.04 | 0.8108 | -- | 0.00 | -- | 0.5491 | -1.41 | -14.95 | -- | 2.89 | -- |
| OraSure Technologies Inc | 125.70m | -60.24m | 197.27m | 501.00 | -- | 0.549 | -- | 1.57 | -0.8107 | -0.8107 | 1.69 | 5.01 | 0.2834 | 2.07 | 4.91 | 250,904.20 | -13.08 | -0.8506 | -14.16 | -0.9596 | 40.41 | 44.80 | -46.15 | -1.39 | 6.20 | -- | 0.0005 | -- | -54.17 | 3.75 | -136.34 | -- | -16.43 | -- |
| Electromed Inc | 66.22m | 8.20m | 200.76m | 177.00 | 26.10 | 4.53 | 21.33 | 3.03 | 0.9295 | 0.9295 | 7.50 | 5.35 | 1.29 | 4.04 | 2.70 | 374,118.70 | 15.99 | 9.33 | 18.99 | 11.04 | 78.04 | 76.56 | 12.38 | 8.40 | 4.66 | -- | 0.00 | 0.00 | 16.97 | 14.53 | 46.35 | 12.62 | -20.72 | -- |
Data as of Feb 13 2026. Currency figures normalised to Lucid Diagnostics Inc's reporting currency: US Dollar USD
20.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 4.32m | 3.29% |
| Masters Capital Management LLCas of 30 Sep 2025 | 4.00m | 3.05% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 3.93m | 3.00% |
| abrdn, Inc.as of 31 Dec 2025 | 3.46m | 2.64% |
| Two Seas Capital LPas of 31 Dec 2025 | 3.00m | 2.29% |
| Ghisallo Capital Management LLCas of 30 Sep 2025 | 2.96m | 2.26% |
| Geode Capital Management LLCas of 31 Dec 2025 | 2.03m | 1.55% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 1.35m | 1.03% |
| Ayrton Capital LLCas of 31 Dec 2024 | 1.20m | 0.92% |
| Perkins Capital Management, Inc.as of 31 Dec 2025 | 1.13m | 0.86% |
More ▼
Data from 30 Sep 2025 - 15 Jan 2026Source: FactSet Research Systems Inc.
